Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cocco

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
The British Journal of Cancer. Supplement|December 1, 1988
From animal to molecule: aspects of the biology of insulin-like growth factorsR S Gilmour, C G Prosser, I R Fleet, et al.
Histology and Histopathology|September 2, 2005
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transductionA M Martelli, R Fiume, I Faenza, et al.
Journal of Cellular Biochemistry|June 8, 2000
Behavior of nucleolar proteins during the course of apoptosis in camptothecin-treated HL60 cellsA M Martelli, I Robuffo, R Bortul, et al.
Biochemical and Biophysical Research Communications|May 31, 1991
Temporal changes in intracellular distribution of protein kinase C in Swiss 3T3 cells during mitogenic stimulation with insulin-like growth factor I and bombesin: translocation to the nucleus follows rapid changes in nuclear polyphosphoinositidesA M Martelli, L M Neri, R S Gilmour, et al.
Current Cancer Drug Targets|December 11, 2012
Dual Inhibition of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin: a Therapeutic Strategy for Acute LeukemiasF Chiarini, C Evangelisti, F Buontempo, et al.
International Journal of Epidemiology|September 1, 1990
Nitrate and nitrite exposure in Italian populations with different gastric cancer ratesT M Knight, D Forman, R Pirastu, et al.
Cancer Research|November 21, 1998
Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cellsA Matteucci, I Faenza, R S Gilmour, et al.
Leukemia|May 23, 2008
PKR is activated in MDS patients and its subcellular localization depends on disease severityM Y Follo, C Finelli, S Mongiorgi, et al.
Cancer Research|March 8, 2000
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor IA M Martelli, G Tabellini, R Bortul, et al.
Leukemia|August 22, 2003
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expressionA Cappellini, G Tabellini, M Zweyer, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
The British Journal of Cancer. Supplement|December 1, 1988
From animal to molecule: aspects of the biology of insulin-like growth factorsR S Gilmour, C G Prosser, I R Fleet, et al.
Histology and Histopathology|September 2, 2005
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transductionA M Martelli, R Fiume, I Faenza, et al.
Journal of Cellular Biochemistry|June 8, 2000
Behavior of nucleolar proteins during the course of apoptosis in camptothecin-treated HL60 cellsA M Martelli, I Robuffo, R Bortul, et al.
Biochemical and Biophysical Research Communications|May 31, 1991
Temporal changes in intracellular distribution of protein kinase C in Swiss 3T3 cells during mitogenic stimulation with insulin-like growth factor I and bombesin: translocation to the nucleus follows rapid changes in nuclear polyphosphoinositidesA M Martelli, L M Neri, R S Gilmour, et al.
Current Cancer Drug Targets|December 11, 2012
Dual Inhibition of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin: a Therapeutic Strategy for Acute LeukemiasF Chiarini, C Evangelisti, F Buontempo, et al.
International Journal of Epidemiology|September 1, 1990
Nitrate and nitrite exposure in Italian populations with different gastric cancer ratesT M Knight, D Forman, R Pirastu, et al.
Cancer Research|November 21, 1998
Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cellsA Matteucci, I Faenza, R S Gilmour, et al.
Leukemia|May 23, 2008
PKR is activated in MDS patients and its subcellular localization depends on disease severityM Y Follo, C Finelli, S Mongiorgi, et al.
Cancer Research|March 8, 2000
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor IA M Martelli, G Tabellini, R Bortul, et al.
Leukemia|August 22, 2003
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expressionA Cappellini, G Tabellini, M Zweyer, et al.
Pageof 20